SCHEMBL16838146

SCHEMBL16838146

Cc1ccc(C(=O)Nc2cc(F)c(F)c(F)c2)cc1S(=O)(=O)N1CCC(O)C1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 1/20 0.57
▸ TP53 P04637 8/20 0.57
▸ MAPT P10636 8/20 0.57
▸ SMN1; SMN2 Q16637 5/20 0.57
▸ CNR1 P21554 4/20 0.54
▸ CYP1A2 P05177 1/20 0.54
▸ CYP3A4 P08684 1/20 0.54
▸ CYP2D6 P10635 1/20 0.54
▸ CYP2C9 P11712 1/20 0.54
▸ CYP2C19 P33261 1/20 0.54
▸ KCNH2 Q12809 1/20 0.54
▸ CNR2 P34972 3/20 0.53
▸ LMNA P02545 3/20 0.53
▸ HTT P42858 3/20 0.53
▸ MAPK1 P28482 2/20 0.53
▸ MEN1 O00255 2/20 0.53
▸ KMT2A Q03164 2/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ RAB9A P51151 2/20 0.50
▸ POLB P06746 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15076702 0.94 THRB (0.62) THRBTP53MAPTSMN1; SMN2CNR1
SCHEMBL16903056 0.93 TP53 (0.62) TP53MAPTSMN1; SMN2CNR1CNR2
SCHEMBL15076358 0.91 CYP3A4 (0.59) TP53MAPTSMN1; SMN2CYP1A2CYP3A4
SCHEMBL21623135 0.91 CYP3A4 (0.59) TP53MAPTSMN1; SMN2CYP1A2CYP3A4
SCHEMBL16903055 0.90 TP53 (0.63) THRBTP53MAPTSMN1; SMN2CNR1
SCHEMBL19157334 0.90 THRB (0.60) THRBTP53MAPTSMN1; SMN2CNR1
SCHEMBL21625036 0.88 CYP3A4 (0.62) THRBTP53MAPTSMN1; SMN2CYP1A2
SCHEMBL15076495 0.88 CYP1A2 (0.56) TP53MAPTSMN1; SMN2CYP1A2CYP3A4
SCHEMBL21623562 0.88 CYP3A4 (0.62) THRBTP53MAPTSMN1; SMN2CYP1A2
SCHEMBL18085481 0.87 TP53 (0.65) THRBTP53MAPTSMN1; SMN2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9061008-B2 Hepatitis B antiviral agents NOVIRA THERAPEUTICS, INC. (US) 2015-06-23 — — US disclosed
Send feedback